Skip to main content
SpringerLink
Log in

VRE control improved with elimination of third-generation cephalosporins

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

VRE control improved with elimination of third-generation cephalosporins. Pharmacoecon. Outcomes News 364, 7 (2002). https://doi.org/10.1007/BF03279117

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03279117

Keywords

Search

Navigation